Antigen Information
General Information of This Antigen (ID: TAR0DEDPZ)
| Antigen Name | Tumor necrosis factor receptor superfamily member 1A (TNFRSF1A) |
|||||
|---|---|---|---|---|---|---|
| Gene Name | TNFRSF1A |
|||||
| Gene ID | ||||||
| Synonym | TNFAR; TNFR1; Tumor necrosis factor receptor 1;Tumor necrosis factor receptor type I;p55;p60;CD120a |
|||||
| Sequence |
MGLSTVPDLLLPLVLLELLVGIYPSGVIGLVPHLGDREKRDSVCPQGKYIHPQNNSICCT
KCHKGTYLYNDCPGPGQDTDCRECESGSFTASENHLRHCLSCSKCRKEMGQVEISSCTVD RDTVCGCRKNQYRHYWSENLFQCFNCSLCLNGTVHLSCQEKQNTVCTCHAGFFLRENECV SCSNCKKSLECTKLCLPQIENVKGTEDSGTTVLLPLVIFFGLCLLSLLFIGLMYRYQRWK SKLYSIVCGKSTPEKEGELEGTTTKPLAPNPSFSPTPGFTPTLGFSPVPSSTFTSSSTYT PGDCPNFAAPRREVAPPYQGADPILATALASDPIPNPLQKWEDSAHKPQSLDTDDPATLY AVVENVPPLRWKEFVRRLGLSDHEIDRLELQNGRCLREAQYSMLATWRRRTPRREATLEL LGRVLRDMDLLGCLEDIEEALCGPAALPPAPSLLR Click to Show/Hide
|
|||||
| Function |
Receptor for TNFSF2/TNF-alpha and homotrimeric TNFSF1/lymphotoxin-alpha. The adapter molecule FADD recruits caspase-8 to the activated receptor. The resulting death-inducing signaling complex (DISC) performs caspase-8 proteolytic activation which initiates the subsequent cascade of caspases (aspartate-specific cysteine proteases) mediating apoptosis. Contributes to the induction of non-cytocidal TNF effects including anti-viral state and activation of the acid sphingomyelinase.
Click to Show/Hide
|
|||||
| Uniprot Entry | ||||||
| HGNC ID | ||||||
| KEGG ID | ||||||
Each Antibody-drug Conjugate and Its Component Related to This Antigen
Full List of The ADC Related to This Antigen
| The Numbers of ADCs, Their Three Components, Payload Targets, and Corresponding Diseases for This Antigens | ||||
|---|---|---|---|---|
Anti-TNF mAb 8c11
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2022171101A1 ADC-47
[1]
|
WO2022171101A1 ADC-47 payload |
Undisclosed |
WO2022171101A1 ADC-47 linker |
|
|
WO2022171101A1 ADC-49
[1]
|
WO2022171101A1 ADC-49 payload |
Undisclosed |
WO2022171101A1 ADC-49 linker |
|
|
WO2023025248A1 ADC-50
[2]
|
WO2023025248A1 ADC-50 payload |
Undisclosed |
WO2023025248A1 ADC-50 linker |
|
|
WO2023025248A1 ADC-51
[2]
|
WO2023025248A1 ADC-51 payload |
Undisclosed |
WO2023025248A1 ADC-51 linker |
|
|
WO2023025248A1 ADC-52
[2]
|
WO2023025248A1 ADC-52 payload |
Undisclosed |
WO2023025248A1 ADC-52 linker |
|
|
WO2023025248A1 ADC-53
[2]
|
WO2023025248A1 ADC-53 payload |
Undisclosed |
WO2023025248A1 ADC-53 linker |
|
|
WO2023025248A1 ADC-54
[2]
|
WO2023025248A1 ADC-54 payload |
Undisclosed |
WO2023025248A1 ADC-54 linker |
|
|
WO2023025248A1 ADC-55
[2]
|
WO2023025248A1 ADC-55 payload |
Undisclosed |
WO2023025248A1 ADC-55 linker |
Anti-TNF mAb alpha-TNF
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
Anti-TNF ADC 121
[3]
|
GRM cpd 17 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 126
[3]
|
GRM cpd 20 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 127
[3]
|
GRM cpd 25 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 128
[3]
|
GRM cpd 26 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 129
[3]
|
GRM cpd 30 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 131
[3]
|
GRM cpd 31 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 134
[3]
|
GRM cpd 64 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 104
[3]
|
GRM cpd 5 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 105
[3]
|
GRM cpd 16 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 106
[3]
|
GRM cpd 17 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 107
[3]
|
GRM cpd 18 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 108
[3]
|
GRM cpd 19 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 109
[3]
|
GRM cpd 20 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 110
[3]
|
GRM cpd 22 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 111
[3]
|
GRM cpd 23 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 112
[3]
|
GRM cpd 24 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 113
[3]
|
GRM cpd 25 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 114
[3]
|
GRM cpd 26 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 115
[3]
|
GRM cpd 30 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 116
[3]
|
GRM cpd 31 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 117
[3]
|
GRM cpd 33 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 118
[3]
|
GRM cpd 61 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 119
[3]
|
GRM cpd 5 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 120
[3]
|
GRM cpd 5 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 123
[3]
|
GRM cpd 19 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 124
[3]
|
GRM cpd 19 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 125
[3]
|
GRM cpd 20 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 130
[3]
|
GRM cpd 31 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 132
[3]
|
GRM cpd 32 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 133
[3]
|
GRM cpd 32 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
|
|
Anti-TNF ADC 135
[3]
|
GRM cpd 63 |
Glucocorticoid receptor (NR3C1) |
MP-Ala-Ala |
Anti-TNF mAb B-II-B059
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2022171101A1 ADC-46
[1]
|
WO2022171101A1 ADC-46 payload |
Undisclosed |
WO2022171101A1 ADC-46 linker |
BIIB059
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2023025248A1 ADC-58
[2]
|
WO2023025248A1 ADC-58 payload |
Undisclosed |
WO2023025248A1 ADC-58 linker |
|
|
WO2023025248A1 ADC-59
[2]
|
WO2023025248A1 ADC-59 payload |
Undisclosed |
WO2023025248A1 ADC-59 linker |
|
|
WO2023025248A1 ADC-60
[2]
|
WO2023025248A1 ADC-60 payload |
Undisclosed |
WO2023025248A1 ADC-60 linker |
|
|
WO2022135332A1 1-12
[4]
|
WO2022135332A1_1-12 payload |
Undisclosed |
WO2022135332A1_1-12 linker |
Iscalimab
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
WO2023025248A1 ADC-57
[2]
|
WO2023025248A1 ADC-57 payload |
Undisclosed |
WO2023025248A1 ADC-57 linker |
Undisclosed
| ADC Name | Payload | Target | Linker | ADC Info |
|---|---|---|---|---|
|
DB-2306
[5]
|
Undisclosed |
Undisclosed |
Undisclosed |
References
